About Us » Core Group

The Core Group (CG) provides leadership and sets the strategic direction for the programs of the WGND. It facilitates and accelerates decision-making and acts as a catalyst for effective implementation of programs and initiatives developed by the membership.

The CG is composed of the WGND Co-Chairs, the Leaders of the WGND Subgroups and a WGND Community Representative. The WGND Secretariat works with the CG to implement the strategic direction and initiatives of the WGND, develop action items and manage and administer WGND programs and the membership.

co-chairs William Bishai, MD, PhD Center for Tuberculosis Research
Johns Hopkins University
1550 Orleans St. Room 108
Baltimore, MD 21231-1001
USA

Mel Spigelman, MD Global Alliance for TB Drug Development
40 Wall Street 24th Floor
New York, NY 10005
USA

biology targets subgroup leader Christopher Locher, PhD Vertex Pharmaceuticals Incorporated
130 Waverly Street
Cambridge, MA 02139-4242
USA

candidates subgroup leader Barbara Laughon, PhD Office of the Director Division of Microbiology and Infectious Diseases
National Institute of Allergy & Infectious Diseases (NIH/NIAID)
6610 Rockledge Drive Room 4207
Bethesda, MD 20892-6603
USA

Critical Knowledge and Tools Subgroup Leaders Jacques Grosset, MD Center for TB Research
CRB II, Rm 105
1550 Orleans Street
Baltimore, MD 21231
USA

Gerhard Walzl, PhD Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University
P.O. Box 19063, Tygerberg, 7505
South Africa

Clinical Trial Capacity Subgroup Leader Christian Lienhardt, MD, PhD Stop TB Partnership Secretariat
World Health Organization
WHO/STB/TBP
20, Avenue Appia
CH-1211 Geneva 27
Switzerland

Community Representative Wim Vandevelde Chair, European AIDS Treatment Group
Place Raymond Blyckaerts 13
B-1050 Brussels
Belgium

Secretariat Lisan Parker, PhD Global Alliance for TB Drug Development
40 Wall St, 24th Floor
New York, NY 10005
USA